Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
ConditionAlzheimers Disease
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age50-90
SponsorHoffmann-La Roche